Trial Profile
Efficacy of Pilsicainide After Radiofrequency Ablation of Paroxysmal Atrial Fibrillation Compared With Other Class IC Anti-arrhythmic Drugs
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Pilsicainide (Primary) ; Flecainide; Propafenone
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 04 Feb 2013 New trial record